Navigation Links
UCB, Inc. Resolves Investigation of Past Keppra® Marketing and Promotional Activities
Date:6/9/2011

ATLANTA, June 9, 2011 /PRNewswire/ -- UCB, Inc. today announced an agreement with the U.S. Department of Justice (DOJ) to resolve a previously disclosed government investigation into the marketing and promotion of Keppra®, an anti-epileptic prescription medicine. As previously reported, the issues that were the subject of this investigation occurred more than six years ago, and as recognized by the DOJ, UCB has cooperated fully with the United States since learning of the investigation in 2008.

Under the agreement, UCB pled guilty to a single misdemeanor violation and agreed to pay USD 8.6 million under the Federal Food, Drug and Cosmetic Act.  UCB also entered into a separate civil settlement agreement and will pay USD 25.8 million plus modest interest to the United States and State Medicaid programs to resolve allegations relating to the False Claims Act. As with many other pharmaceutical settlements, UCB also agreed to enter into a five-year corporate integrity agreement (CIA) with the Office of Inspector General of the U.S. Department of Health and Human Services.

This CIA builds upon and requires the maintenance of UCB's existing compliance program. The commitments in the CIA are also consistent with UCB's previously stated commitment to comply with the laws and regulations that govern the pharmaceutical industry as evidenced last year by the company's voluntary public certification to adhere to PhRMA's Code on Interactions with Healthcare Professionals.

"UCB takes compliance with all applicable laws, policies, and procedures very seriously and remains committed to the highest standards of corporate conduct," said Greg Duncan, UCB's President for North American Operations. "We have worked diligently over the years to enhance our compliance program and we continue to evolve our compliance efforts to meet the changing demands of the regulatory environment in which we operate. We are pleased to have resolved this matter a
'/>"/>

SOURCE UCB, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
2. Amgen Resolves EPO Patent Dispute With Roche
3. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
4. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
5. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
6. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
7. Bayer to Present Data on Investigational Oncology Compounds at 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)
8. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
9. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
10. Investigational Drug May Reduce Involuntary Movements in People With Parkinsons Disease
11. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
(Date:3/3/2015)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... specialty pharmaceutical company focused on pharmaceuticals for women,s health, ... Annual ROTH Conference, which will take place from March ... Dana Point, California . Management,s presentation will take ... Time (12:00 p.m. Eastern Time) in the Promenade room. ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... the "Global Ultrasound Equipment Market 2015-2019" ... The Global Ultrasound Equipment market to grow ... 2014-2019 Ultrasound equipment are used to ... are extensively used by cardiologists, radiologists, surgeons, obstetricians, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... Sept. 2, 2011 The overall success of ... markets sector. Access to formularies and relationships with ... growth for pharmaceutical organizations. Given the importance of ... account executives, performance is a critical undertaking for ...
... Cox Business have partnered to make a new, diagnostically ... the Valley and across the state at the same ... first dedicated outpatient offering of breast tomosynthesis in Arizona ... Sub-specialty trained radiologists at SimonMed can now ...
Cached Medicine Technology:Assessing the Performance of Account Executives for the Critical Managed Markets Sector 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
(Date:3/3/2015)... Il. (PRWEB) March 03, 2015 The ... is set to reveal the world’s first fully integrated ... are breathing and controls an air purifier to remove ... user informed, and in control, via phone, tablet or ... purifiers in over 50 countries worldwide, will unveil its ...
(Date:3/3/2015)... UK (PRWEB) March 03, 2015 The ... growth of the augmentation market. The wearable augmentation sector ... terms of size in the upcoming years. , ... market owing to a big number of new products ... North American region, high technological advancements as well as ...
(Date:3/3/2015)... Daylight Savings Time may lead to your ... tips for parents. , Parents and their children may feel ... when they set their clocks forward one hour for Daylight ... -- one hour earlier -- you will have already lost ... thinking about “sleep hygiene” for their kids and teens this ...
(Date:3/3/2015)... Sunday, March 1, through Saturday, March 7, is ... year, every region of the country is at risk for ... Insurance is sharing the following tips from the Centers ... you safe in the event of severe weather: , Winter ... frequently to prevent loss of body heat. Wear warm, loose-fitting, ...
(Date:3/3/2015)... — (PRWEB) March 03, 2015 -- vRad ... and radiology practice, today announced that Arlene Sussman, MD, ... will host a live webinar to explore how telemedicine ... specialized breast imaging services for women virtually anywhere. Click ... Breast Imaging Service Line” on March 4, 2015 at ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4
Medtronic, Inc., a world leader in therapies for restoring people with chronic conditions to full life, introduces the AT500 Pacing System for the management of atrial tachyarrhythmias and bradycardi...
The first-ever pacemaker to include Managed Ventricular Pacing (MVP), the EnRhythm Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary right ventr...
... 3000Dx (GCS3000Dx) is the first microarray instrumentation ... consists of the FS450Dx Fluidics Station which ... array, the GCS3000Dx Scanner with AutoLoader Dx ... to be scanned without operator intervention, and ...
... compact system capable of B-mode, M-mode, ... intuitive operation, high mobility, and exceptional ... incorporates an alphanumeric keyboard, several one-touch ... toggle keys for application specific functions. ...
Medicine Products: